Oak Thistle LLC’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.34M Sell
16,967
-28,622
-63% -$2.43M 0.13% 282
2026
Q1
$3.93M Buy
+45,589
New +$4.09M 0.38% 67
2025
Q3
Sell
-27,791
Closed -$1.64M 532
2025
Q2
$1.64M Buy
+27,791
New +$1.8M 0.24% 150
2025
Q1
Sell
-4,547
Closed -$376K 482
2024
Q4
$376K Buy
+4,547
New +$359K 0.11% 298
2024
Q2
Sell
-7,440
Closed -$399K 354
2024
Q1
$399K Sell
7,440
-8,597
-54% -$462K 0.36% 112
2023
Q4
$855K Buy
16,037
+7,196
+81% +$351K 0.25% 166
2023
Q3
$439K Buy
8,841
+3,789
+75% +$212K 0.13% 325
2023
Q2
$301K Sell
5,052
-79
-2% -$4.5K 0.16% 250
2023
Q1
$291K Buy
+5,131
New +$329K 0.17% 269
2022
Q3
Sell
-4,686
Closed -$263K 165
2022
Q2
$263K Buy
+4,686
New +$308K 0.51% 90

Other funds holding GMED

Oak Thistle LLC's GMED Position: Q2 2026 in Review

Oak Thistle LLC reduced its Globus Medical (GMED) stake by 63% in Q2 2026, selling an estimated $2.43M and leaving 16,967 shares worth $1.34M. The position accounts for 0.13% of the portfolio, ranked #282.

Oak Thistle LLC first reported a position in GMED in Q2 2022 and has held it in 10 quarters since. The position peaked at $3.93M in Q1 2026. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Oak Thistle LLC held 16,967 shares of Globus Medical worth $1.34M as of Q2 2026.
  • Oak Thistle LLC sold 28,622 Globus Medical shares in Q2 2026, an estimated $2.43M.
  • Globus Medical made up 0.13% of Oak Thistle LLC's portfolio in Q2 2026, its #282 holding.
  • Oak Thistle LLC first reported a position in Globus Medical in Q2 2022 and has held it in 10 quarters since.
  • Oak Thistle LLC's Globus Medical position peaked at $3.93M in Q1 2026.
  • 599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Oak Thistle LLC's 13F filing for Q2 2026, filed 21 Jul 2026.